Email Alert | RSS    帮助

中国防痨杂志 ›› 2000, Vol. 22 ›› Issue (2): 83-85.

• 论著 • 上一篇    下一篇

胸腔内注入尿激酶辅助治疗结核性纤维化性胸腔积液的临床观察

郝金柱;曲海燕;张春盛;王晓萍;綦继光;孟凡敏;   

  1. 山东省胸科医院 250013;
  • 收稿日期:1999-08-24 修回日期:1999-11-16 出版日期:2000-02-10 发布日期:2000-02-10

Clinical observation of intrapleural injection of urokinase for patients with encapsulated tuberculous pleural effusion

HAO Jinzhu,QU Haiyan,ZHANG Chunsheng,et al.   

  1. Shandong Chest Hospital,Jinan 250013
  • Received:1999-08-24 Revised:1999-11-16 Online:2000-02-10 Published:2000-02-10

摘要: 目的 确定尿激酶在治疗结核性包裹性胸腔积液的作用?方法 在规则抗痨下 ,对 2.1例结核性包裹性胸腔积液的病人胸腔内注入尿激酶 50.00.0U +异烟肼 0 3g/日 ,1.4例应用胸腔内注入强的松龙1.25mg+异烟肼 0.3g/日作对照?平均引流天数为 5天?结果 治疗组 2.1例中 ,94.3 % ( 1.9/2.1 )达到完全好转 ,4.29% ( 6/1.4 )达到部分好转 ,1.3 4 % ( 3 /1.4 )无效?结论 在规则抗痨治疗下 ,配合胸腔内注入尿激酶治疗结核性包裹性胸腔积液可增加引流量 ,减轻胸膜厚度 ,并改善肺功能?

关键词: 尿激酶, 胸腔积液, 结核, 胸膜

Abstract: Objective To determine the effects of intrapleural injection of urokinase for patients with encapsulated tuberculous pleural effusion.Methods Regular antituberculosis treatment was given to all patients observed.Urokinase and INH were injected 50.000U/day and 300mg/day respectively into the pleural cavity of 21 patients with encapsulated tuberculous pleural effusion for 5 days.While prednisolone of 125mg/day plus INH of 300mg/day were injected into the pleural cavity of 14 patients of the control group.Results 94.3%(19/21)of the 21 cases of the study group achieved complete improvement and another 5.7%(2/21)of the studied cases achieved partial improvement.While in control group,complete improvement occurred only in 35.7%(5/14),partial improvement was seen in 42.9%(6/14) and inefficacy remaind among the other 13.4%(3/14)of the patients.Conclusion For patients with encapsulated tuberculous pleural effusion,regular antituberculosis treatemnt plus urokinase injection into the pleural cavity can increase the drainage,decrease pleural thichening and improve pulmonary function of the patients.

Key words: Urokinase, Pleural effusion, Tuberculosis, pleural